- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06755034
Stabilizing Mandibular Overdentures with a Single Implant Placed in the Canine Region of the Preferred Chewing Side (c-SIMO)
March 25, 2025 updated by: Frauke Müller
Stabilizing Mandibular Overdentures with a Single Implant Placed in the Canine Region of the Preferred Chewing Side Compared to the Midline Single-implant Overdenture Treatment Concept: an RCT with 5 Years of Follow-up
The investigators are evaluating the use of a single implant to stabilize complete dentures in the lower jaw, in the canine region of the preferred chewing side.
They are conducting this study to determine whether this treatment concept gives satisfactory results, and how it compares with the standard position in the center of the lower jaw.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sabrina Maniewicz
- Phone Number: +4122 379 40 60
- Email: sabrina.maniewicz@unige.ch
Study Locations
-
-
-
Geneva, Switzerland, 1211
- Recruiting
- University Clinics of Dental Medicine, University of Geneva
-
Contact:
- Sabrina Maniewicz
- Phone Number: +41223794060
- Email: sabrina.maniewicz@unige.ch
-
Contact:
- Sabrina Maniewicz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Informed consent signed by the subject
- Age ≥ 60 years
- Edentulous and wearing sufficient complete maxillary and mandibular dentures or ones that can be rendered sufficient via a reline and/or renewal of the prosthetic teeth
- Healed edentulous mandible (minimum 6-8 weeks since last extraction in the anterior zone (4-4) and one year in the posterior zone (5-8))
- Physical status ASA1 and ASA2
Exclusion Criteria:
- Contraindications to the medical devices used, e.g. known hypersensitivity or allergy
- Vulnerable subjects
- Enrollment of the investigator, his/her family members, employees and other dependent persons
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to perform adequate oral hygiene
- Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, Parkinson etc. of the subject (Dementia: clock-drawing test score ≤ 5)
- Surgical risk factors such as, but not limited to, uncontrolled diabetes, immunosuppression, radiation, chemotherapy, or antiresorptive medication (ex. Bisphosphonates)
- Heavy smoking habit: >20 cig/d
- Reported severe bruxism or clenching habits, clinically present oro-facial pain
- Depression: Geriatric Depression Scale > 9
- Xerostomia: SSFR ≤ 0.7ml/min
- Ridge dimensions <6 mm (width) by 10 mm (height) in the canine or midline area
- Ridge defects requiring bone augmentation procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: c-SIMO
Placement of an implant in the mandibular canine area and using it to stabilize a pre-existing mandibular complete denture.
|
Placement of an implant in the mandibular canine area and using it to stabilize a pre-existing mandibular complete denture.
|
|
Active Comparator: m-SIMO
Placement of an implant in the midline of the mandible and using it to stabilize a pre-existing mandibular complete denture.
|
Placement of an implant in the midline of the mandible and using it to stabilize a pre-existing mandibular complete denture.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
OHIP-EDENT
Time Frame: From baseline to 5-year follow-up
|
Oral health-related quality of life questionnaire
|
From baseline to 5-year follow-up
|
|
DSI
Time Frame: From baseline to 5-year follow-up
|
Denture Satisfaction Index (questionnaire)
|
From baseline to 5-year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preferred chewing side
Time Frame: From baseline to 5-year follow-up
|
Asymmetry Index
|
From baseline to 5-year follow-up
|
|
Chewing efficiency
Time Frame: From baseline to 5-year follow-up
|
two-color mixing ability test
|
From baseline to 5-year follow-up
|
|
Occlusal analysis
Time Frame: From baseline to 5-year follow-up
|
Dental Prescale System
|
From baseline to 5-year follow-up
|
|
Plaque index
Time Frame: From implant loading to 5-year follow-up
|
modified Plaque Index (modPI)
|
From implant loading to 5-year follow-up
|
|
Bleeding on probing
Time Frame: From implant loading to 5-year follow-up
|
modified Bleeding Index (modBI)
|
From implant loading to 5-year follow-up
|
|
Pocket probing depth
Time Frame: From implant loading to 5-year follow-up
|
Peri-implant probing depth
|
From implant loading to 5-year follow-up
|
|
Keratinized peri-implant tissues
Time Frame: From implant loading to 5-year follow-up
|
Measurement of the keratinized tissue around implants
|
From implant loading to 5-year follow-up
|
|
Prosthodontic assessment
Time Frame: From implant loading to 5-year follow-up
|
Number of prosthetic complications
|
From implant loading to 5-year follow-up
|
|
Peri-implant bone height
Time Frame: From implant loading to 5-year follow-up
|
Measured on radiographs
|
From implant loading to 5-year follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sabrina Maniewicz, University of Geneva
- Study Director: Frauke Müller, University of Geneva
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2025
Primary Completion (Estimated)
December 1, 2031
Study Completion (Estimated)
December 1, 2031
Study Registration Dates
First Submitted
December 15, 2024
First Submitted That Met QC Criteria
December 23, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Estimated)
March 26, 2025
Last Update Submitted That Met QC Criteria
March 25, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DGPA_2024_02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Completely Edentulous Patients
-
Ain Shams UniversityCompletedCompletely Edentulous PatientsEgypt
-
Nermeen Ahmed HassanUnknownCompletely Edentulous Patients
-
Suez Canal UniversityCompletedCompletely Edentulous PatientsEgypt
-
Iman Abd-ElWahab Radi, PhDCompletedCompletely Edentulous PatientsEgypt
-
Cairo UniversityCompletedDiabetes Free Completely Edentulous PatientsEgypt
-
Mansoura UniversityActive, not recruitingCompletely Edentulous | Implant AssesmentEgypt
-
Ain Shams UniversityCompletedCompletely EdentulousEgypt
-
Ain Shams UniversityActive, not recruiting
-
Ain Shams UniversityActive, not recruiting
-
Cairo UniversityUnknown
Clinical Trials on c-SIMO
-
Guangxi Medical UniversityCompleted
-
Guangxi Medical UniversityCompleted
-
IlDong Pharmaceutical Co LtdCompleted
-
International Centre for Diarrhoeal Disease Research...University of California, DavisCompletedMalnourished Children
-
ANRS, Emerging Infectious DiseasesEuroVacc FoundationCompletedHIV InfectionsFrance, Switzerland
-
Joshua M HareCompletedHypoplastic Left Heart SyndromeUnited States
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
Direction Centrale du Service de Santé des ArméesRecruitingEating Habit | Cold Exposure | HeatFrance
-
Kolon Life ScienceCompletedDegenerative ArthritisKorea, Republic of
-
MetseraCompletedObesity and OverweightUnited States